Silo Pharma Collaborates With Medspray Pharma For Intranasal Technology For Stress Disorder Candidate - SILO Pharma (NASDAQ:SILO)
Silo Pharma Inc (NASDAQ: SILO) announced a new exclusive license agreement with Medspray Pharma BV for its proprietary patented soft mist nasal spray technology, the delivery mechanism selected for Silo's intranasal therapeutic drug SPC-15.